New stent aims to safely unclog bile ducts when standard treatment fails

NCT ID NCT05169398

Recruiting now Symptom relief Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new type of stent designed to drain bile from the liver in patients whose bile ducts are blocked by cancer. The stent is placed using an endoscope guided by ultrasound, without major surgery. The goal is to see if the stent is safe and works well in 20 adults who cannot have the usual ERCP procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MG-biliary stent (Niti-S)
What this could lead to: If successful, this new stent could provide a safer way to drain bile in patients with cancer-related bile duct blockages when standard methods fail.
What could go wrong: This is a small early study with only 20 participants, so results may not apply to everyone. There is a risk of serious complications like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT BILIARY OBSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

biliary tract cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT BILIARY OBSTRUCTION

Contacts and locations

Locations

Department of Surgery, Prince of Wales Hospital
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.